Homepage
Greater London
Greater London Legal Chronicle
Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics

Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics

September 13, 2022 Martina Bellini Greater London Legal Chronicle

Tagged: Amy Francis Ducentis BioTherapeutics Goodwin Procter Graham Defries Heidi Fitchett Kenny Walker-Durrant Lucy Sharples Matthew Shelley Michael Grainger Robert Young

In UK Goodwin Procter, advised on the matter.Goodwin Procter advised Ducentis BioTherapeutics with a team including Graham Defries (Picture – Life Science & Health Care), Robert…

This content is for members only.
Login Join Now

Author: Martina Bellini

…

This content is for members only.
Login Join Now

View all posts by Martina Bellini

Tillman Infrastructure’s $500 Million Financing

Trident Energy’s Acquisition of the Republic of Congo’s Oil Fields

KPS Capital Partners’ Acquisition of Sport Group

Modutec’s Acquisition Of Majority Stake In SeaKing

Air IT’s Acquisition of SCS Technology Solutions

Bedford Greenacre Independent School’s Multi-Million-Pound Funding Package for their New Site

Rock Road’s £100 Million Zero-Emission Buses Financing

Calcivis’ £5 Million Funding Round

Kinetics Controls & Innovation Ltd.’s Transition to Employee Ownership Trust

Mapletree Investments’ S$1.7 Billion Acquisition of Student Housing

Powerhouse Energy’s Framework Agreement with National Hydrogen

Preservation Capital Partners’ €459 Million Closing of PCP Fund II

McDermott Further Strengthens London Transactions Practice with Another Private Equity Partner

Fieldfisher Expands Pensions Practice With a Four Team Hire

McDermott Strengthens London Office with Senior Appointment

Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics

Author: Martina Bellini